Reporting owner · CIK 0001352908

Hayden Michael R

Visual SEC Form 4 history across 2 companies, 2 transactions and 2 filings.

DIRAbCellera Biologics Inc.
Open-market mix
Filings2Form 4 records
Buying$570.4K1 purchases
Selling$00 sales
Net value$570.4KBuys minus sells
Companies22 securities
Most recentAug 24, 2026buy

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Average return+15.3%Across 1 open-market buy
Median return+15.3%Half the buys outperformed this
How it's computed

For every open-market buy (Form 4 code P, acquisition A) in the selected window, we take the closing price on the transaction date and 90 calendar days later, then compute the percentage change. The figures shown are the simple average and median of those per-buy returns.

  • Window follows the rest of the summary (all-history or last 3 months).
  • Only buys with a resolved price context are counted.
  • Includes both positive and negative outcomes; gains and losses net out at the per-buy level.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-5Feb 251Aug 26

Net value flow

Buys minus sells

Feb 25
$0
Aug 26
$570.4K

Transaction texture

Ownership and ticket size

Average P/S size$570.4K
Median P/S size$570.4K
Direct1
Indirect1
Aug 24, 2026buy

Latest Form 4 facts

Quick context from source filings

Latest transaction

buy at AbCellera Biologics Inc. on Aug 24, 2026 valued at $570,442.

Review SEC filing
Latest buy

buy at AbCellera Biologics Inc. on Aug 24, 2026 valued at $570,442.

Review SEC filing
Latest sale

No open-market insider sale is available.

TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
ABCLHayden Michael R
DIR
buy53.6k$57.0MP+15.3%08/2408/24
ETNBHayden Michael R
DIR
grant56.4k$0A02/05/202502/03/2025

Hayden Michael R Insider Activity FAQ

SEC Form 4 context

Who is Hayden Michael R?

Hayden Michael R is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001352908.

Which companies has Hayden Michael R reported transactions for?

AbCellera Biologics Inc., 89bio, Inc.

When was Hayden Michael R's latest insider buy?

buy at AbCellera Biologics Inc. on Aug 24, 2026 valued at $570,442.

When was Hayden Michael R's latest insider sale?

No open-market insider sale is available for this period.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.